Innovative cardiac treatment takes a fresh approach with "heart-to-heart" chats at a fresh England hospital. 

Catholic Medical Center's New England Heart & Vascular Institute in Manchester, N.H., offers cutting-edge technologies and procedures to improve patients' lives.  

Every February, during American Heart Month, CMS hosts free “heart-to-heart” community talks with cardiology professionals. 

In January 2024, CMC implemented the world's first twin chamber leadless pacemaker technology to treat abnormal or sluggish heart rhythms. 

The Abbott pacemaker “offers a new, minimally invasive option to treat the nearly 80% of people who require pacing in two chambers of the heart (both the right atrium and left ventricle),” according to CMC.  

Leadless device implantation is less invasive and eliminates cardiac leads, lowering lead- and infection-related problems and minimizing recovery time. 

CMS's cardiac and vascular teams innovate often. CMC was the first New England hospital to implant the WATCHMAN and WATCHMAN FLX, which greatly reduce stroke risk in non-valvular atrial fibrillation patients.  

As of 2022, CMC clinicians have implanted 600 WATCHMAN devices since 2015. 

CMC's community outreach is as innovative as its treatments. 

Love Horoscope For February 1, 2024 Brings Change

For More WebStories